– UK, Amersham – Halma PLC (LON: HLMA), the FTSE 100 global group of life-saving technology companies, today announced the appointment of Giles Kerr to its Board as an independent non-executive Director, effective from 1 February 2024, bringing a wealth of experience gained across a variety of roles in life sciences, technology, and industrial businesses.
“I am delighted that Giles is joining the Halma Board. His extensive executive and non-executive experience, particularly in the life sciences and technology sectors, will bring valuable insights and perspectives to the Board,” said Board Chair, Dame Louise Makin.
Giles Kerr will also join the Audit, Remuneration, and Nomination Committees.
The company also announced that Roy Twite will step down from the Board on 7 June 2024.
About Giles Kerr
Giles Kerr has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director and Audit Committee Chair at Abcam plc until it was acquired by Danaher in December 2023.
His executive career included senior financial roles at Arthur Andersen, Amersham plc, and as Finance Director at Oxford University Innovation. Since 2007, Giles Kerr has held several non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc, and Senior plc.
SOURCE: https://www.halma.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.